Results 181 to 190 of about 786,314 (373)
Arthritis Care &Research, Accepted Article.Objectives Evaluate the efficacy and safety of baricitinib in paediatric patients with active JIA‐U or chronic anterior ANA‐positive uveitis, who had an inadequate response to MTX or bDMARDs. Methods JUVE‐BRIGHT was an open‐label, active‐controlled, Phase‐3 multicentre trial which utilized a novel design, including 1:1 randomization to an active ...
Athimalaipet V. Ramanan +7 more
wiley +1 more source
Arthritis Care &Research, Accepted Article.Objective This systematic review aimed to assess the diagnostic accuracy of algorithms used to identify rheumatoid arthritis (RA) and juvenile idiopathic arthritis (JIA) in electronic health records (EHRs). Methods We searched MEDLINE, Embase, and CENTRAL databases and included studies that validated case definitions against a reference standard such ...
Constanza Saka‐Herrán +10 more
wiley +1 more source
Keeping the Commitment: A Progress Report on Four Early Leaders in Patient Safety Improvement [PDF]
, 2011 Examines four healthcare systems' expansion of patient safety interventions over five years through the development of practical training methods, effective tools for minimizing errors, an emphasis on goal setting and accountability, and other ...
Douglas McCarthy, Sarah Klein
core
Disproportionality analysis of reslizumab based on the FDA Adverse Event Reporting System
Therapeutic Advances in Drug SafetyBackground: With the increasing prescription of reslizumab for severe asthma with an eosinophilic phenotype, a real-world pharmacovigilance analysis of reslizumab is urgently required to detect potential unreported adverse events (AEs) in clinical ...
Huqun Li, Cuilian Guo, Chongshu Wang
doaj +1 more source
Post-Marketing Pharmacovigilance of Canakinumab from the FDA Adverse Event Reporting System (FAERS)
PharmaceuticalsBackground: Canakinumab, a humanized anti-IL-1β monoclonal antibody, is known for its ability to suppress IL-1β-mediated inflammation. However, continuous monitoring of its safety remains essential.
Weidong Zhang +5 more
doaj +1 more source
Analysis of the time-to-onset of osteonecrosis of jaw with bisphosphonate treatment using the data from a spontaneous reporting system of adverse drug events [PDF]
, 2015 Mitsuhiro Nakamura +9 more
openalex +1 more source
Financial Distress and its Determinants in Rheumatoid Arthritis
Arthritis Care &Research, Accepted Article.Objective To quantify the degree of financial distress and identify its determinants in adults with rheumatoid arthritis (RA) given the frequent chronic use of expensive disease modifying therapies. Methods We identified adults enrolled in the FORWARD databank with either RA or non‐inflammatory musculoskeletal disease (NIMSKD) completing the Functional
Amber Brown Keebler +5 more
wiley +1 more source
Drug-induced dermatomyositis: a pharmacovigilance study of the FDA adverse event reporting system
Frontiers in PharmacologyBackgroundDermatomyositis (DM) is an autoimmune disease that may be triggered by certain medications. However, most studies have focused on specific drugs, lacking a comprehensive overview. This study uses the FDA’s Adverse Event Reporting System (FAERS)
Jianing Bi +5 more
doaj +1 more source
Chorioamnionitis following vaccination in the Vaccine Adverse Event Reporting System [PDF]
, 2015 Hema Datwani +3 more
openalex +1 more source